Investing.com - Financial Markets Worldwide
📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI.See top stocks

BioNTech SE (B1NT34)

B3
Symbol
Exchange
Currency
B1NT34B3BRL
BNTXNASDAQUSD
BNTXNBIVAMXN
22UAyTradeGateEUR
22UAyFrankfurtEUR
22UAyXetraEUR
BNTXViennaEUR
Currency in BRL
Disclaimer
41.84
+0.36(+0.87%)
Delayed Data

B1NT34 Cash Flow Statement

Advanced Cash Flow Statement
Collapse All
Period Ending:
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa13,577.45,371.4
Cash from Operations Growth
Net Income
Depreciation & Amortisation, Total
Amortisation of Deferred Charges, Total
Other Non-Cash Items, Total
Change in Net Operating Assets
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-35.3-6,954.5
Cash from Investing Growth
Capital Expenditure
Sale of Property, Plant, and Equipment
Cash Acquisitions
Divestitures
Other Investing Activities
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-1,419.3-778.6
Cash from Financing Growth
Total Debt Issued
Short Term Debt Issued, Total
Long-Term Debt Issued, Total
Total Debt Repaid
Short Term Debt Repaid, Total
Long-Term Debt Repaid, Total
Issuance of Common Stock
Repurchase of Common Stock
Issuance of Preferred Stock
Repurchase of Preferred Stock
Common & Preferred Stock Dividends Paid
Special Dividend Paid
Other Financing Activities
Foreign Exchange Rate Adjustments
Miscellaneous Cash Flow Adjustments
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa12,182.4-2,211.4
Beginning Cash Balance
Ending Cash Balance
Levered Free Cash Flow
Levered Free Cash Flow Growth
Free Cash Flow Yield
* In Millions of EUR (except for per share items)